Xu, Chuan
Liu, Mingshan
Li, Yang
Peng, Xiaoyue
Zhou, Wei
Zhang, Wan
Zhang, Jingtao
Yu, Bentong
Funding for this research was provided by:
Jiangxi Provincial Natural Science Foundation (20212ACB206014)
the Science and Technology Program of Health Commission of Jiangxi Province (2024ZD004)
the Introduction of Training High-level Innovative Undertaking Talents in Jiangxi Province "One Thousand People Plan (jxsg2023201025)
the National Natural Science Foundation of China (82260561)
Article History
Received: 29 July 2024
Accepted: 17 February 2025
First Online: 6 March 2025
Declarations
:
: This study was approved by the Tumor Gene Atlas Project of the First Affiliated Hospital of Nanchang University and approved by the Ethics Committee of the First Affiliated Hospital of Nanchang University on May 1, 2022 (Approval Number. 202203005). All study involving human experiments was informed written consent from all participants and in accordance with the Helsinki Declaration of Ethics Principles for Medical Research.
: The authors declare no competing interests.